Molecular Mechanisms of Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia: Ongoing Challenges and Future Treatments
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cells 9, 11
- Schlagwort
-
-
- Ereignis
-
Veröffentlichung
- (wo)
-
Greifswald
- (wer)
-
Universität Greifswald
- (wann)
-
2020
- Urheber
-
Scholl, Sebastian
Fleischmann, Maximilian
Schnetzke, Ulf
Heidel, Florian H.
- DOI
-
10.3390/cells9112493
- URN
-
urn:nbn:de:gbv:9-opus-41978
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Scholl, Sebastian
- Fleischmann, Maximilian
- Schnetzke, Ulf
- Heidel, Florian H.
- Universität Greifswald
Entstanden
- 2020
Ähnliche Objekte (12)
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
FLT3 specific antibody-drug-conjugate for the treatment of acute myeloid leukemia
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
The role of the juxtamembrane dDomain of FLT3-ITDs in acute myeloid leukemia
P53 haploinsufficiency cooperates with FLT3-ITD to induce the development of acute myeloid leukemia
Chimeric antigen receptor (CAR)-modified T cells targeting FLT3 in acute myeloid leukemia (AML)
Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia
Patient specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
FLT3 specific antibody-drug-conjugate for the treatment of acute myeloid leukemia
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
The role of the juxtamembrane dDomain of FLT3-ITDs in acute myeloid leukemia
P53 haploinsufficiency cooperates with FLT3-ITD to induce the development of acute myeloid leukemia
Chimeric antigen receptor (CAR)-modified T cells targeting FLT3 in acute myeloid leukemia (AML)
Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia
Patient specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
FLT3 specific antibody-drug-conjugate for the treatment of acute myeloid leukemia
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
The role of the juxtamembrane dDomain of FLT3-ITDs in acute myeloid leukemia
P53 haploinsufficiency cooperates with FLT3-ITD to induce the development of acute myeloid leukemia
Chimeric antigen receptor (CAR)-modified T cells targeting FLT3 in acute myeloid leukemia (AML)
Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia
Patient specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia